Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

qz.com - Bruce Gil - Big Pharma just hiked prices for more than 250 drugs
Big Pharma just hiked prices for more than 250 drugs
Quartz

Pharmaceutical companies are raising the price of over 250 brand drugs this year. Nearly all the price increases are under 10%, with the median increase across all the affected medications being 4.5%, matching the median increase last year, Reuters…

axios.com - Alison Snyder - Pharma looks for quantum leap in drug development
Pharma looks for quantum leap in drug development
Axios

Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop better drugs and cut the time and cost of finding new ones. Why it matters: Quantum computing is advancing, but it still hasn't…

business-standard.com - Capital Market - Kwality Pharma gains on securing RCGM approval for Erythropoietin
Kwality Pharma gains on securing RCGM approval for Erythropoietin
Business Standard

Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant Erythropoietin product, 10,000 1U/mL. Erythropoietin…

theepochtimes.com - Crystal-Rose Jones - Pop Artist Splits From Manager, Song Label Over Lyrics Criticising Big Pharma, Cancel Culture
Pop Artist Splits From Manager, Song Label Over Lyrics Criticising Big Pharma, Cancel Culture
The Epoch Times

An Australian pop singer and medical doctor says she parted ways with her manager and label after refusing to change the lyrics to a new song that has gone viral. Iyah May's “Karmageddon” is a social commentary on recent events…

business-standard.com - Religare Broking's Ajit Mishra says buy these pharma, QSR and auto stocks
Religare Broking's Ajit Mishra says buy these pharma, QSR and auto stocks
Business Standard

The markets began the calendar year on a positive note, gaining nearly half a percent. After an initial decline, buying interest in select heavyweight stocks across sectors quickly erased losses, gradually pushing the index higher. As a result, the…

wsj.com - Megan Graham - What RFK Jr.'s Dislike for Drug TV Commercials Could Mean for the Ad Industry
What RFK Jr.'s Dislike for Drug TV Commercials Could Mean for the Ad Industry
Wall Street Journal

Robert F. Kennedy Jr.'s stated desire to ban drug commercials from TV seems unlikely to become reality, according to advertising experts, but even pressure from Washington that falls short of an outright ban could lead to changes in the…

firstpost.com - FP Staff - Sensex leaps 1,500 points on consumption boost, 6 factors pushing latest surge
Sensex leaps 1,500 points on consumption boost, 6 factors pushing latest surge
Firstpost

The Indian benchmark indices started the New Year 2025 on a positive note and extended their upward trend on Thursday with BSE Sensex surging past 1,500 points and Nifty 50 surpassing 24,000-mark. On Thursday, January 2, 2025, BSE Sensex ended…

albertvilella.substack.com - Albert - RXRX Recursion Pharma enters 2025 ahead of the techbio curve
RXRX Recursion Pharma enters 2025 ahead of the techbio curve
Rhymes with Haystack

Recursion Pharmaceuticals is a TechBio company combining computational biology, machine learning, and high-throughput phenotyping via heavy automation to accelerate drug discovery and development. The company, led by CEO Chris Gibson, went public…

techcrunch.com - Anna Heim - Apheris rethinks the AI data bottleneck in life science with federated computing
Apheris rethinks the AI data bottleneck in life science with federated computing
TechCrunch

AI is fundamentally dependent on data, but the vast majority of health data goes unused for understandable reasons — chiefly patient privacy, regulation and IP protection. “This is the core underlying problem” of building AI…

business-standard.com - Deepak Korgaonkar - This SME stock surges 98% in 2 months; zoomed 839% against issue price
This SME stock surges 98% in 2 months; zoomed 839% against issue price
Business Standard

Afcom Holdings share's dream run continued on the BSE, with the stock hitting a new high at Rs 1,014.65; frozen at the 5 per cent upper circuit in Thursday's intra-day trade. The market price of the SME (Small and Medium Enterprises) company was…

business-standard.com - Sirali Gupta - Sensex soars 1,000 pts; Nifty tops 24k; What's boosting stock market today?
Sensex soars 1,000 pts; Nifty tops 24k; What's boosting stock market today?
Business Standard

The Indian market surged in trade on Thursday, January 2, 2025. The BSE Sensex added 1,085.09 points or 1.3 per cent and logged an intraday high at 79,592.5, similarly, the National Stock Exchange (NSE) Nifty advanced 328.45 points or 1.3 per cent…

dailymail.co.uk - Jason Chester for MailOnline - Katherine Ryan hits back after daughter accused her of using Ozempic
Katherine Ryan hits back after daughter accused her of using Ozempic
Mail Online

Do YOU have a story? Email tips@dailymail.com Katherine Ryan has denied turning to controversial weight loss jabs after her own daughter accused her of using them to slim down. The mother-of-three hit back at eldest child Violet, 14, after the…

thisismoney.co.uk - Jon Hopkins - MARKET REPORT: Vodafone picks up as it sells Italian arm for £7bn
MARKET REPORT: Vodafone picks up as it sells Italian arm for £7bn
This is Money

It might have been a new year, but the biggest corporate news on the first session of 2025 came from a number of old deals completing. Vodafone said it had finalised the sale of its Italian operations to Swisscom for £6.6billion. As part of…

deccanchronicle.com - Falaknaaz Syed - Sensex Nears 80K, Nifty Touches 24188
Sensex Nears 80K, Nifty Touches 24188
Deccan Chronicle

MUMBAI: The Indian equity markets continued its positive rally for the second consecutive trading session of 2025 with bullish sentiment driving Thursday's performance. Throughout the day, buyers dominated the market, leading to a strong finish.

appliedclinicaltrialsonline.com - Elizabeth Hickman  - A Shifting CDMO Landscape: The Rise of High-Science, High-Touch
A Shifting CDMO Landscape: The Rise of High-Science, High-Touch
Applied Clinical Trials Online

Throughout my career as a chief business officer and strategy executive, I have had the privilege of leading and contributing to critical initiatives in business model design, change leadership, capabilities expansion, M&A, and innovative research.

Receive a Daily briefing on Pharma Industry News

Get Started